Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
iXensor CoROCO:6734 +0.31%54 Receivables Turnover is 70.66 as of Dec. 2025. GuruFocus rates ROCO:6734 with a GF Score™ of 54/100 and a GF Value™ of NT$5.70 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 813 Medical Devices & Instruments companies, iXensor Co ranks better than 99.26% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. iXensor Co's Revenue for the
six
months ended in Dec. 2025 was NT$14.34 Mil. iXensor Co's average Accounts Receivable for the
six
months ended in Dec. 2025 was NT$0.20 Mil.
Hence, iXensor Co's Receivables Turnover for the
six
months ended in Dec. 2025 was 70.66.
iXensor Co (ROCO:6734) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
iXensor Co Receivables Turnover Related Terms
iXensor Co Receivables Turnover Historical Data
* Premium members only.
The historical data trend for iXensor Co's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6734 vs ABT, SYK, MDT: Receivables Turnover Comparison
For the Medical Devices subindustry, iXensor Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iXensor Co Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iXensor Co's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where iXensor Co's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iXensor Co (ROCO:6734) has a Receivables Turnover of 70.66 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on iXensor Co and its competitors. According to the industry distribution chart, iXensor Co ranks #6 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 0.7%.
Is iXensor Co's Receivables Turnover too high?
iXensor Co's current Receivables Turnover is 70.66. The Medical Devices & Instruments industry median Receivables Turnover is 5.60. iXensor Co's value of 70.66 is 1161.8% above this industry median. Based on the distribution chart, iXensor Co ranks #6 out of 813 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, iXensor Co has a GF Score™ of 54/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does iXensor Co's Receivables Turnover compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, iXensor Co ranks #6 out of 813 companies for Receivables Turnover. This places iXensor Co in the top 1% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.60. iXensor Co's value of 70.66 is 1161.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.60, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. iXensor Co's current Receivables Turnover of 70.66 is 1161.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on iXensor Co and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iXensor Co's current Receivables Turnover is 70.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iXensor Co stock overvalued right now?
Based on GuruFocus' analysis, iXensor Co (ROCO:6734) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$5.70, compared to a current price of NT$6.43 — trading 12.8% above its estimated fair value. The current Receivables Turnover is 70.66 and 1161.8% above the Medical Devices & Instruments industry median of 5.60. iXensor Co's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For iXensor Co (ROCO:6734), the current Receivables Turnover is 70.66 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iXensor Co (ROCO:6734) Overvalued in 2026?
Based on GuruFocus' analysis, iXensor Co stock appears to be overvalued.
The current stock price of NT$6.43 is trading 12.8% above its estimated GF Value™ of NT$5.70.
GuruFocus considers iXensor Co to be Modestly Overvalued.
Key valuation signals for ROCO:6734:
Receivables Turnover: 70.66
GF Value™: NT$5.70 vs. price of NT$6.43 (12.8% above fair value)
Industry Position: 1161.8% above the Medical Devices & Instruments median (#6 of 813)
No single metric tells the full story. See the ROCO:6734 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
iXensor Co Ltd is a Taiwan based company involved in research and development, manufacturing and sales of medical equipment. Its PixoTest technology utilizes the lighting and image sensing module of the smartphone or mobile device to detect the color change reaction on the biochemical test strip. This enables the users to monitor their conditions of diabetes, cardiovascular diseases, women health problems, or infectious diseases.
54GF Score
Get the complete analysis for ROCO:6734
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6734 has been successfully added to your 
